Low-dose acetylsalicylic acid for the prevention of pre-eclampsia.

Autor:	Andersen MF; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet., Rode L; Afdeling for Klinisk Biokemi, Københavns Universitetshospital - Rigshospitalet Glostrup., Christiansen ILR; Center for Føtal Medicin, Københavns Universitetshospital - Rigshospitalet., Tabor A; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet.; Center for Føtal Medicin, Københavns Universitetshospital - Rigshospitalet., Ekelund CK; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet.; Center for Føtal Medicin, Københavns Universitetshospital - Rigshospitalet.
Jazyk:	dánština
Zdroj:	Ugeskrift for laeger [Ugeskr Laeger] 2024 Apr 29; Vol. 186 (18).
DOI:	10.61409/V10230682
Abstrakt:	Pre-eclampsia affects 3-4% of pregnancies and is associated with maternal and infant mortality and morbidity. High-risk pregnancies in Denmark are recommended prophylactic low-dose acetylsalicylic acid (LDA). If new screening algorithms are implemented, LDA will be recommended to around 10% of pregnant women. The use of LDA may slightly increase the risk of minor bleeding disturbances. Otherwise, there is a lot of promising data regarding the safety of LDA use during pregnancy, as argued in this review. (Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu